| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hanmi Science (KO: 008930)
008930 Technical Analysis
4
| As on 30th Dec 2025 008930 STOCK Price closed @ 36250.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 35297.42 & Strong Buy for SHORT-TERM with Stoploss of 29380.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
008930STOCK Price
| Open | 36550.00 | Change | Price | % |
| High | 36950.00 | 1 Day | -500.00 | -1.36 |
| Low | 35900.00 | 1 Week | -850.00 | -2.29 |
| Close | 36250.00 | 1 Month | -4200.00 | -10.38 |
| Volume | 112799 | 1 Year | 550.00 | 1.54 |
| 52 Week High 51900.00 | 52 Week Low 25000.00 | ||||
KO Korea Most Active Stocks
| 093230 | 33.00 | -49.23% |
| 093230 | 33.00 | -49.23% |
| 093240 | 1698.00 | 13.43% |
| 093240 | 1698.00 | 13.43% |
| 152550 | 383.00 | 19.69% |
| 152550 | 383.00 | 19.69% |
| 096300 | 156.00 | -6.02% |
| 096300 | 156.00 | -6.02% |
| 168490 | 159.00 | 29.27% |
| 168490 | 159.00 | 29.27% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
| 008930 Daily Charts |
008930 Intraday Charts |
Whats New @ Bazaartrend |
008930 Free Analysis |
|
|
008930 Important Levels Intraday
| RESISTANCE | 38273.35 |
| RESISTANCE | 37624.45 |
| RESISTANCE | 37223.35 |
| RESISTANCE | 36822.25 |
| SUPPORT | 35677.75 |
| SUPPORT | 35276.65 |
| SUPPORT | 34875.55 |
| SUPPORT | 34226.65 |
008930 Forecast January 2026
| 4th UP Forecast | 49064.6 |
| 3rd UP Forecast | 44954.9 |
| 2nd UP Forecast | 42414.6 |
| 1st UP Forecast | 39874.2 |
| 1st DOWN Forecast | 32625.8 |
| 2nd DOWN Forecast | 30085.4 |
| 3rd DOWN Forecast | 27545.2 |
| 4th DOWN Forecast | 23435.4 |
008930 Weekly Forecast
| 4th UP Forecast | 42416.40 |
| 3rd UP Forecast | 40438.80 |
| 2nd UP Forecast | 39216.40 |
| 1st UP Forecast | 37994.00 |
| 1st DOWN Forecast | 34506.00 |
| 2nd DOWN Forecast | 33283.60 |
| 3rd DOWN Forecast | 32061.20 |
| 4th DOWN Forecast | 30083.60 |
008930 Forecast2026
| 4th UP Forecast | 91265.9 |
| 3rd UP Forecast | 73622 |
| 2nd UP Forecast | 62715.9 |
| 1st UP Forecast | 51809.8 |
| 1st DOWN Forecast | 20690.2 |
| 2nd DOWN Forecast | 9784.15 |
| 3rd DOWN Forecast | -1121.95 |
| 4th DOWN Forecast | -18765.8 |
Hanmi Science ( KO Korea Symbol : 008930 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
008930 Business Profile
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea. Address: 14, Wiryeseong-daero, Seoul, South Korea
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service